Campylobacter spp. is one of the main cause of bacterial gastroenteritis in the world. The increase of antibiotic resistance in this species is a threat to public health. A Campylobacter spp. surveillance study was performed in Italy in the 2013-2016 period by the Enter-Net Italia network. The most prevalent Campylobacter species identified causing gastroenteritis was Campylobacter jejuni (73.4%) and 45% of all the annual cases of campylobacteriosis were reported in the summer period. High rates of ciprofloxacin and tetracycline resistance in Campylobacter spp. have been observed. An increasing percentage of Campylobacter coli strains simultaneously resistant to ciprofloxacin, tetracycline and erythromycin has been found. Molecular mechanisms of resistance have been investigated and the role of efflux pumps evaluated. Antibiotic resistance in Campylobacter spp. is an increasing serious threat that requires coordinated action to minimize the emergence and spread of antimicrobial resistant strains from animals to humans throughout the food chain. © 2018 García-Fernández, Dionisi, Arena, Iglesias-Torrens, Carattoli and Luzzi.

Human campylobacteriosis in Italy: emergence of multi-drug resistance to ciprofloxacin, tetracycline, and erythromycin / García-Fernández, A; Dionisi, Am; Arena, S; Iglesias-Torrens, Y; Carattoli, A; Luzzi, I.. - In: FRONTIERS IN MICROBIOLOGY. - ISSN 1664-302X. - 9:AUG(2018). [10.3389/fmicb.2018.01906]

Human campylobacteriosis in Italy: emergence of multi-drug resistance to ciprofloxacin, tetracycline, and erythromycin

Carattoli A;
2018

Abstract

Campylobacter spp. is one of the main cause of bacterial gastroenteritis in the world. The increase of antibiotic resistance in this species is a threat to public health. A Campylobacter spp. surveillance study was performed in Italy in the 2013-2016 period by the Enter-Net Italia network. The most prevalent Campylobacter species identified causing gastroenteritis was Campylobacter jejuni (73.4%) and 45% of all the annual cases of campylobacteriosis were reported in the summer period. High rates of ciprofloxacin and tetracycline resistance in Campylobacter spp. have been observed. An increasing percentage of Campylobacter coli strains simultaneously resistant to ciprofloxacin, tetracycline and erythromycin has been found. Molecular mechanisms of resistance have been investigated and the role of efflux pumps evaluated. Antibiotic resistance in Campylobacter spp. is an increasing serious threat that requires coordinated action to minimize the emergence and spread of antimicrobial resistant strains from animals to humans throughout the food chain. © 2018 García-Fernández, Dionisi, Arena, Iglesias-Torrens, Carattoli and Luzzi.
2018
2 naphthylamine; ciprofloxacin; DNA topoisomerase (ATP hydrolysing) A; erythromycin; fusion protein; phenylalanine arginine 2 naphthylamide; ribosomal protein L22; ribosomal protein L4; ribosome protein; RNA 23S; tetracycline; unclassified drug, amino acid sequence; antibiotic resistance; antibiotic sensitivity; Article; bacterium isolation; Campylobacter concisus; Campylobacter fetus; Campylobacter jejuni; Campylobacter lari; Campylobacter upsaliensis; campylobacteriosis; computer model; disk diffusion; DNA sequence; efflux ratio; feces analysis; female; gene mutation; genetic code; human; Italy; male; multidrug resistance; phenotype; polymerase chain reaction; prevalence; survival analysis; zone of inhibition
01 Pubblicazione su rivista::01a Articolo in rivista
Human campylobacteriosis in Italy: emergence of multi-drug resistance to ciprofloxacin, tetracycline, and erythromycin / García-Fernández, A; Dionisi, Am; Arena, S; Iglesias-Torrens, Y; Carattoli, A; Luzzi, I.. - In: FRONTIERS IN MICROBIOLOGY. - ISSN 1664-302X. - 9:AUG(2018). [10.3389/fmicb.2018.01906]
File allegati a questo prodotto
File Dimensione Formato  
Carattoli_Multi-drugs-resistance.pdf

accesso aperto

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 858.68 kB
Formato Adobe PDF
858.68 kB Adobe PDF

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1284215
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 38
  • ???jsp.display-item.citation.isi??? 33
social impact